Promising results in phase 1 trial lead immatics to continue work on vaccine (IMA950) for glioblastoma
A NEW cancer vaccine (IMA950) for glioblastoma has met the two primary endpoints of safety and immunogenicity in a trial conducted by Cancer Research UK....
Revolutionary clinical trial aims to advance lung cancer treatment thanks to Cancer Research UK and Pharma partnership
Cancer Research UK is partnering with pharmaceutical companies to create a pioneering clinical trial for patients with advanced lung cancer
In a British Journal of Cancer study, scientists have uncovered a link between cholesterol and prostate cancer’s ability to spread to the bones.